Evidence map›Paper›PMID 36551372›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Study of SarA by DNA Affinity Capture Assay (DACA) Employing Three Promoters of Key Virulence and Resistance Genes in Methicillin-Resistant

Byungchan Kim, Hong-Ju Lee, Sung-Hyun Jo, Min-Gyu Kim, Yeonhee Lee, Wonsik Lee, Wooseong Kim, Hwang-Soo Joo, Yun-Gon Kim, Jae-Seok Kim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. CRISPR-driven strategies to disrupt methicillin-resistantFrontiers in cellular and infection microbiology · 2026
    Review
  2. Molecules (Basel, Switzerland) · 2025
    Article
  3. Microorganisms · 2025
    Article
  4. Article
  5. Article
  6. Molecules (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Byungchan KimDepartment of Biological Engineering, College of Engineering, Konkuk University, Seoul 05029, Republic of Korea.
Hong-Ju LeeDepartment of Biological Engineering, College of Engineering, Konkuk University, Seoul 05029, Republic of Korea.
Sung-Hyun JoDepartment of Chemical Engineering, Soongsil University, 511 Sangdo-dong, Seoul 06978, Republic of Korea.ORCID 0000-0002-2854-1568
Min-Gyu KimDepartment of Chemical Engineering, Soongsil University, 511 Sangdo-dong, Seoul 06978, Republic of Korea.
Yeonhee LeeDepartment of Biotechnology, College of Engineering, Duksung Women's University, Seoul 01370, Republic of Korea.
Wonsik LeeDepartment of Pharmacy, School of Pharmacy, Sungkyunkwan University, Suwon-si 16419, Republic of Korea.
Wooseong KimCollege of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.ORCID 0000-0002-4597-8374
Hwang-Soo JooDepartment of Biotechnology, College of Engineering, Duksung Women's University, Seoul 01370, Republic of Korea.ORCID 0000-0003-4668-3225
Yun-Gon KimDepartment of Chemical Engineering, Soongsil University, 511 Sangdo-dong, Seoul 06978, Republic of Korea.
Jae-Seok KimDepartment of Laboratory Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul 05355, Republic of Korea.ORCID 0000-0001-6025-0341
Yung-Hun YangDepartment of Biological Engineering, College of Engineering, Konkuk University, Seoul 05029, Republic of Korea.
Konkuk University · KRSoongsil University · KRDuksung Women's University · KREwha Womans University · KRHallym University · KRSungkyunkwan University · KR

Funding

Ministry of Science and ICT 2017M3A9E4077234MOTIE/KEIT 20014350National Research Foundation of Korea (NRF) NRF-2022M3I3A1082545National Research Foundation of Korea (NRF) NRF-2022M3J4A1053702National Research Foundation of Korea (NRF) NRF-2022R1A2C2003138
6 · The paper itself

Abstract

Methicillin-resistant

Indexed as

clinical strainDACAMRSAsarAvirulence factors

Identifiers

PMID36551372
PMCPMC9774152
OpenAlexW4310154625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.